BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16415905)

  • 1. A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.
    Pugliese AM; Coppi E; Spalluto G; Corradetti R; Pedata F
    Br J Pharmacol; 2006 Mar; 147(5):524-32. PubMed ID: 16415905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
    Pugliese AM; Latini S; Corradetti R; Pedata F
    Br J Pharmacol; 2003 Sep; 140(2):305-14. PubMed ID: 12970092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration.
    Pugliese AM; Coppi E; Volpini R; Cristalli G; Corradetti R; Jeong LS; Jacobson KA; Pedata F
    Biochem Pharmacol; 2007 Sep; 74(5):768-79. PubMed ID: 17626785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.
    Pugliese AM; Traini C; Cipriani S; Gianfriddo M; Mello T; Giovannini MG; Galli A; Pedata F
    Br J Pharmacol; 2009 Jul; 157(5):818-30. PubMed ID: 19422385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase 1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro.
    Traini C; Pedata F; Cipriani S; Mello T; Galli A; Giovannini MG; Cerbai F; Volpini R; Cristalli G; Pugliese AM
    Eur J Neurosci; 2011 Jun; 33(12):2203-15. PubMed ID: 21453436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxygen and glucose deprivation on synaptic transmission in rat dentate gyrus: role of A2A adenosine receptors.
    Maraula G; Traini C; Mello T; Coppi E; Galli A; Pedata F; Pugliese AM
    Neuropharmacology; 2013 Apr; 67():511-20. PubMed ID: 23261865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices.
    Latini S; Bordoni F; Corradetti R; Pepeu G; Pedata F
    Br J Pharmacol; 1999 Nov; 128(5):1035-44. PubMed ID: 10556941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective antagonism of P2X7 and P2Y1 receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrus.
    Maraula G; Lana D; Coppi E; Gentile F; Mello T; Melani A; Galli A; Giovannini MG; Pedata F; Pugliese AM
    PLoS One; 2014; 9(12):e115273. PubMed ID: 25526634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Selective Antagonism of Adenosine A
    Fusco I; Ugolini F; Lana D; Coppi E; Dettori I; Gaviano L; Nosi D; Cherchi F; Pedata F; Giovannini MG; Pugliese AM
    Front Pharmacol; 2018; 9():399. PubMed ID: 29740323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
    Sperlágh B; Zsilla G; Baranyi M; Illes P; Vizi ES
    Neuroscience; 2007 Oct; 149(1):99-111. PubMed ID: 17850981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of a novel adenosine A
    Fusco I; Cherchi F; Catarzi D; Colotta V; Varano F; Pedata F; Pugliese AM; Coppi E
    Brain Res Bull; 2019 Sep; 151():174-180. PubMed ID: 31132418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons.
    Hentschel S; Lewerenz A; Nieber K
    Restor Neurol Neurosci; 2003; 21(1-2):55-63. PubMed ID: 12808203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the pyridoindole SMe1EC2 and compounds affecting A(1) and A(2A) adenosine receptors in rat hippocampus under ischemia in vitro.
    Gáspárová Z; Jariabka P; Stolc S
    Pharmacol Rep; 2008; 60(3):353-60. PubMed ID: 18622060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors.
    Guinzberg R; Cortés D; Díaz-Cruz A; Riveros-Rosas H; Villalobos-Molina R; Piña E
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E940-51. PubMed ID: 16352677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen/glucose deprivation induces a reduction in synaptic AMPA receptors on hippocampal CA3 neurons mediated by mGluR1 and adenosine A3 receptors.
    Dennis SH; Jaafari N; Cimarosti H; Hanley JG; Henley JM; Mellor JR
    J Neurosci; 2011 Aug; 31(33):11941-52. PubMed ID: 21849555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices.
    Coppi E; Pugliese AM; Stephan H; Müller CE; Pedata F
    Purinergic Signal; 2007 Jun; 3(3):203-19. PubMed ID: 18404434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the anoxia-induced long-term synaptic potentiation in area CA1 of the rat hippocampus.
    Hsu KS; Huang CC
    Br J Pharmacol; 1997 Oct; 122(4):671-81. PubMed ID: 9375963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.
    Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Traini C; Pugliese AM; Pedata F; Morizzo E; Moro S
    Bioorg Med Chem; 2008 Jun; 16(11):6086-102. PubMed ID: 18468446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.